Alaunos Therapeutics | ARS: Annual Report to Security Holders
Apr 27 04:55
Alaunos Therapeutics | DEFA14A: Others
Apr 27 04:54
Alaunos Therapeutics | DEF 14A: Definitive information statements
Apr 27 04:51
Alaunos Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 16 05:25
Alaunos Therapeutics | 10-K: Annual report
Apr 1 19:36
Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Groenewald Ferdinand
Feb 29 10:49
Alaunos Therapeutics | 8-K: Current report
Feb 23 05:49
Alaunos Therapeutics | 8-K: Current report
Feb 21 05:10
Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Discovery Capital Management, LLC(1.66%),Robert K. Citrone(1.66%), etc.
Feb 15 01:49
Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MSD Partners, L.P.(9.2%),MSD Credit Opportunity Master Fund, L.P.(9.2%), etc.
Feb 14 07:21
Alaunos Therapeutics | 8-K: Current report
Feb 2 01:17
Alaunos Therapeutics | 8-K: Current report
Jan 29 21:48
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hogue Dale Curtis Jr.
Jan 23 13:00
Alaunos Therapeutics | 8-K: Current report
Jan 22 13:00
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hogue Dale Curtis Jr.
Jan 3 13:00
Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hogue Dale Curtis Jr.
Jan 3 13:00
Alaunos Therapeutics | 8-K: Current report
Jan 2 13:00
Alaunos Therapeutics | 8-K: Current report
Dec 28, 2023 13:00
Alaunos Therapeutics | 8-K: Current report
Dec 22, 2023 21:00
Alaunos Therapeutics | 8-K: Current report
Nov 15, 2023 20:30
No Data
No Data